CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenue
Diagnostic testing services	$ 1,872,798	$ 24,124
Product sales	470	0
Total revenue	1,873,268	24,124
Cost of revenue
Diagnostic testing services	1,206,312	0
Product sales	1,642	0
Total cost of revenue	1,207,954	0
Gross profit	665,314	24,124
Selling expenses	546,854	237,838
Research and development expenses	797,225	422,503
General and administrative expenses	2,605,111	1,774,708
Total operating expenses	3,949,190	2,435,049
Operating loss	(3,283,876)	(2,410,925)
Interest income	279	143
Interest expense	1,784	749
Other losses	49,910
Loss before income taxes	(3,335,291)	(2,411,531)
Income taxes	0	0
Net loss	$ (3,335,291)	$ (2,411,531)
Loss per common share - basic and diluted (in dollars per share)	$ (0.13)	$ (0.1)
Weighted Average Number Of Shares Outstanding, Basic and Diluted	24,916,867	24,419,060